Results of a Phase IV study published in The Lancet find no safety concerns with coadministration of the COVID-19 vaccine and the influenza vaccine.

Getting involved in research can provide a competitive edge needed to secure postgraduate opportunities after pharmacy school.

New research published in the New England Journal of Medicine found that a combination of the monoclonal antibodies casirivimab and imdevimab, REGEN-COV, significantly reduced the risk of COVID-19–related hospitalizations and death in patients. The study results were part of the phase 3 portion of an adaptive trial.